A triple receptor agonist peptide (GLP-1, GIP and glucagon) manufactured under GMP-aligned conditions and supplied lyophilized with full batch documentation. Intended for laboratory and preclinical research workflows.
Home / Products / Weight Management & Metabolic Regulation
Weight Management & Metabolic Regulation
Retatrutide
Synonym(s): LY-3437943, Triple Receptor Agonist, GLP-1/GIP/GCGR
- CAS2381089-83-9
- FormulaC221H342N46O68
- Mol. weight4731.33 g/mol
- EC / EINECSNot applicable (synthetic)
Packaging & availability
Pricing on request| Select | SKU | Pack size | Per box | Availability | Price |
|---|---|---|---|---|---|
| RT10 | 10 mg/vial | 10 vials/box | On request | On request | |
| RT20 | 20 mg/vial | 10 vials/box | On request | On request | |
| RT30 | 30 mg/vial | 10 vials/box | On request | On request | |
| RT60 | 60 mg/vial | 10 vials/box | On request | On request |
Add the sizes you need to a quote request — our team will follow up with pricing and lead time.
| CAS | 2381089-83-9 |
|---|---|
| Linear Formula | C221H342N46O68 |
| Mol. weight | 4731.33 g/mol |
| Purity / Grade | ≥99%, GMP Research Grade, Lyophilized |
| EC / EINECS | Not applicable (synthetic) |
| Synonym(s) | LY-3437943, Triple Receptor Agonist, GLP-1/GIP/GCGR |
| Storage | Store at 2–8°C |
For research and manufacturing use only. Not for human or veterinary use, diagnosis, or treatment. Supplied to qualified businesses only.
Hazard statements
Always review the Safety Data Sheet before handling. Use appropriate personal protective equipment and follow your facility's chemical hygiene plan.
Download SDS